PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer

The purpose of the current study is to investigate the prognostic significance of M2 isoform of pyruvate kinase (PKM2) mRNA expression loss in patients with operable colon cancer (CC). Two hundred sixty-two specimens from patients with stage-III or high-risk stage-II CC (group-A) treated with adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Sfakianaki, Maria, Papadaki, Chara, Tzardi, Maria, Trypaki, Maria, Manolakou, Stavroula, Messaritakis, Ippokratis, Saridaki, Zenia, Athanasakis, Elias, Mavroudis, Dimitrios, Tsiaoussis, John, Gouvas, Nikolaos, Souglakos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465271/
https://www.ncbi.nlm.nih.gov/pubmed/32722474
http://dx.doi.org/10.3390/cancers12082058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465271/
https://www.ncbi.nlm.nih.gov/pubmed/32722474
http://dx.doi.org/10.3390/cancers12082058

Ejemplares similares